Self-administration of D1 receptor agonists by squirrel monkeys

Psychopharmacology

Volumn 125, Issue 2, 1996, Pages 97-104

  Grech, Doreen M ^a,b   Spealman, Roger D ^a   Bergman, Jack ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

(+) PHNO (+) 4 propyl 9 hydroxynaphthoxazine ; 1H 3 benzazepine ; R,S 6 chloro 7,8 dihydroxy 3 allyl 1 phenyl 2,3,4,5 ; Cocaine; D1 agonist; D2 agonist; Dopamine; Fixed ratio; Quinpirole; Second order; Self administration; SKF 77434 R,S 7,8 dihydroxy 3 allyl 1 phenyl 2,3,4,5 tetrahydro ; SKF 81297 R,S 6 chloro 7,8 dihydroxy 1 phenyl 2,3,4,5 tetrahydro 1H 3 benzazepine ; SKF 82958; Squirrel monkey; tetrahydro 1H 3 benzazepine

Indexed keywords

3 ALLYL 2,3,4,5 TETRAHYDRO 1 PHENYL 1H 3 BENZAZEPINE 7,8 DIOL; 3 ALLYL 6 CHLORO 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 6 CHLORO 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; COCAINE; DOPAMINE 1 RECEPTOR; DOPAMINE 1 RECEPTOR STIMULATING AGENT; DOPAMINE 2 RECEPTOR; DOPAMINE 2 RECEPTOR STIMULATING AGENT; NAXAGOLIDE; PSYCHOSTIMULANT AGENT; QUINPIROLE; 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; BENZAZEPINE DERIVATIVE; DOPAMINE RECEPTOR STIMULATING AGENT; DRUG DERIVATIVE; SK&F 77434; SK&F 81297; SK&F 82958;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; DRUG ABUSE; DRUG EFFICACY; DRUG MECHANISM; DRUG SELECTIVITY; DRUG SELF ADMINISTRATION; INSTRUMENTAL CONDITIONING; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; REINFORCEMENT; SQUIRREL MONKEY; ANIMAL; ANIMAL BEHAVIOR; CEBIDAE; COMPARATIVE STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG POTENTIATION;

2,3,4,5-TETRAHYDRO-7,8-DIHYDROXY-1-PHENYL-1H-3-BENZAZEPINE; ANIMALS; BEHAVIOR, ANIMAL; BENZAZEPINES; DOPAMINE AGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; RECEPTORS, DOPAMINE D1; SAIMIRI; SELF ADMINISTRATION;

EID: 0029659006     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02249407     Document Type: Article

References (55)

1. 1 receptor efficacy. Eur J Pharmacol 188: 335-347
2. Baxter BL, Gluckman MI, Stein L, Scerni RA (1974) Self-injection of apomorphine in the rat: positive reinforcement by a dopamine receptor stimulant. Pharmacol Biochem Behav 2: 387-391
3. Bergman J, Johanson CE (1985) The reinforcing properties of diazepam under several conditions in the rhesus monkey. Psychopharmacology 86: 108-113
4. 1 antagonists: comparison with other drugs and modification by haloperidol. J Pharmacol Exp Ther 245: 471-478
5. 2 antagonists. Behav Pharmacol 1: 355-363
6. 2 receptor agonists on schedule-controlled behavior of squirrel monkeys. J Pharmacol Exp Ther 273: 40-48
7. 1 receptor ligands: drug interaction studies in squirrel monkeys. J Pharmacol Exp Ther 276: 942-950
8. Briggs CA, Pollock NJ, Frail DE, Paxson CL, Rakowski RD, Kang CH, Kebabian JW (1991) Activation of the 5-HT1c receptor expressed in Xenopus oocytes by the benzazepines SCH 23390 and SKF 38393. Br J Pharmacol 104: 1038-1044
9. 2 antagonists on cocaine self-administration under different schedules of reinforcement in the rat. J Pharmacol Exp Ther 270: 209-218
10. 2 dopamine antagonists. Pharmacol Biochem Behav 39: 799-802
11. 1 dopamine agonists with varying efficacies in the MPTP-treated common marmoset. Psychopharmacology 117: 275-286
12. Goldberg SR (1973) Comparable behavior maintained under fixed-ratio and second-order schedules of food presentation, cocaine injection or d-amphetamine injection in the squirrel monkey. J Pharmacol Exp Ther 186: 18-30
13. Gonzalez FA, Goldberg SR (1977) Effects of cocaine and d-amphetamine on behavior maintained under various schedules of food presentation in squirrel monkeys. J Pharmacol Exp Ther 201: 847-852
14. 3H-dopamine uptake in rat brain tissue slices. Biochem Pharmacol 24: 847-852
15. Herd JA, Morse WH, Kelleher RT, Jones LG (1969) Arterial hypertension in the squirrel monkey during behavioral experiments. Am J Physiol 217: 24-29
16. Hoffmeister F, Schlichting UU (1972) Reinforcing properties of some opiates and opioids in rhesus monkeys with histories of cocaine and codeine self-administration. Psychopharmacology 23: 55-74
17. 2 dopamine antagonists on cocaine self-administration in the rat. Psychopharmacology 105: 151-156
18. 1 receptor agonists for stimulating adenylyl cyclase in squirrel monkey and rat. Eur J Pharmacol 246: 39-44
19. Kamien JB, Woolverton WL (1989) A pharmacological analysis of the discriminative stimulus properties of d-amphetamine in rhesus monkeys. J Pharmacol Exp Ther 248: 938-946
20. 1 dopamine agonists on schedule-controlled behavior in squirrel monkeys. Behav Pharmacol 6: 143-148
21. Kebabian JW, Calne DB (1979) Multiple receptors for dopamine. Nature 277: 93-96
22. Kelleher RT, Goldberg SR (1976) General introduction: control of drug-taking behavior by schedules of reinforcement. Pharmacol Rev 27[3]: 291-300
23. Kleven MS, Anthony EW, Woolverton WL (1990) Pharmacological characterization of the discriminative stimulus effects of cocaine in rhesus monkeys. J Pharmacol Exp Ther 254: 312-317
24. Koe BK (1976) Molecular geometry of inhibitors of the uptake of catecholamines and serotonin in synaptosomal preparations of rat brain. J Pharmacol Exp Ther 199: 649-661
25. 1 dopamine receptor antagonist SCH 23390 increases cocaine self-administration in the rat. Neurosci Lett 79: 315-320
26. Melia KF, Spealman RD (1991) Pharmacological characterization of the discriminative stimulus effects of GBR 12909. J Pharmacol Exp Ther 258: 626-632
27. 2 interaction. Eur J Pharmacol 160: 377-384
28. 1 receptors depends on intrinsic activity. Neuropharmacology 31: 177-183
29. 1 dopamine receptor. Neuropharmacology 28: 401-405
30. 2 agonists in squirrel monkeys. J Pharmacol Exp Ther 271: 138-145
31. Pfeiffer FR, Wilson JW, Weinstock J, Kuo GY, Chambers PA, Holden KG, Hahn RA, Wardell JR, Tobia AJ, Setler PE, Sarau HM (1982) Dopaminergic activity of substituted 6-chloro-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines. J Med Chem 25: 352-358
32. Raiteri M, Bertollini A, Angelini F, Levi G (1975) d-Amphetamine as a releaser or reuptake inhibitor of biogenic amines in synaptosomes. Eur J Pharmacol 34: 189-195
33. Reith MEA, Meisler BE, Sershen H, Lajtha A (1986) Structural requirements for cocaine cogeners to interact with dopamine and serotonin uptake sites in mouse brain and to induce stereo-typed behaviors. Biochem Pharmacol 35: 1123-1129
34. 1 stimulation. Life Sci 33: 2479-2482
35. 2 agonist (+)-4-propyl-9-hydroxynapthoxazine by dopamine antagonists in monkeys. J Pharmacol Exp Ther 265: 1039-1046
36. 1 receptor involvement in the discriminative stimulus effects of SKF 81297 in squirrel monkeys. J Pharmacol Exp Ther 267: 765-775
37. 2 agonists in squirrel monkeys. Psychopharmacology 116: 9-18
38. Rosenzweig-Lipson S, Madras BK, Spealman RD, Bergman J (1994b) Comparison of the behavioral effects of SKF 81297, SKF 82958 and cocaine in squirrel monkeys. NIDA Res Monogr 141: 285
39. Schwartz JC, Giros B, Martres MP, Sokoloff P (1992) The dopamine receptor family: molecular biology and pharmacology. Neurosciences 4: 99-108
40. 1 agonists SKF 82958 and SKF 77434 are sell-administered by rats. Brain Res 582: 349-352
41. Spealman RD, Kelleher RT (1979) Behavioral effects of self-administered cocaine: responding maintained alternately by cocaine and electric shock in squirrel monkeys. J Pharmacol Exp Ther 210: 206-214
42. Spealman RD, Bergman B, Madras BK, Melia KF (1991) Discriminative stimulus effects of cocaine in squirrel monkeys: involvement of dopamine receptor subtypes. J Pharmacol Exp Ther 258: 945-953
43. 2 dopamine receptors in the behavioral effects of cocaine. Neurochem Int 20: 1475-1525
44. 1 agonist SKF 38393. Psychopharmacology 113: 328-333
45. 2 agonists. In: Problems of drug dependence 1995. NIDA Res Monogr. US Govt Printing Office, Washington, DC (in press)
46. 1-like dopamine receptor that couples to activation of phosphoinositide metabolism in brain. J Neurochem 62: 2045-2048
47. 1 receptor agonists display a different intrinsic activity in rat, monkey and human astrocytes. Eur J Pharmacol Mol Pharmacol 269: 121-125
48. 1 dopamine agonist SKF 81297 in rhesus monkeys. Psychopharmacology 113: 51-52
49. 1 receptor agonists in rhesus monkeys. J Pharmacol Exp Ther 275: 1367-1374
50. Witkin JM, Nichols DF, Terry P, Katz JL (1991) Behavioral effects of selective dopaminergic compounds in rats discriminating cocaine injections. J Pharmacol Exp Ther 257: 706-713
51. Woodward RM, Panicker MM, Miledi R (1992) Actions of dopamine and dopaminergic drugs on cloned serotonin receptors expressed in Xenopus oocytes. Proc Natl Acad Sci USA 89: 4708-4712
52. 2 dopamine antagonist on the self-administration of cocaine and piribedil by rhesus monkeys. Pharmacol Biochem Behav 24: 531-535
53. Woolverton WL, Goldberg LI, Ginos JZ (1984) Intravenous self-administration of dopamine receptor agonists by rhesus monkeys. J Pharmacol Exp Ther 229: 678-683
54. Yokel RA, Wise RA (1978) Amphetamine-type reinforcement by dopaminergic agonists in the rat. Psychopharmacology 58: 289-296
55. Young AM, Woods JH (1981) Maintenance of behavior by ketamine and related compounds in rhesus monkeys with different self-administration histories. J Pharmacol Exp Ther 218: 720-727